Efficacy and Safety of Melphalan, Cyclophosphamide and Dexamethasone (MCD) as a Salvage Treatment for Patients with Relapsed/Refractory Multiple Myeloma

This study investigated the efficacy and safety of melphalan, cyclophosphamide, and dexamethasone (MCD) as a salvage regimen for heavily treated relapsed or refractory multiple myeloma patients. We retrospectively analyzed a total of 27 patients who received the MCD regimen between April 2011 and No...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung-Shin, Lee, Je-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chonnam National University Medical School 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351330/
https://www.ncbi.nlm.nih.gov/pubmed/30740337
http://dx.doi.org/10.4068/cmj.2019.55.1.25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351330/
https://www.ncbi.nlm.nih.gov/pubmed/30740337
http://dx.doi.org/10.4068/cmj.2019.55.1.25

Ejemplares similares